Opzelura (ruxolitinib) cream 1.5% is a topical JAK inhibitor used on the skin. Like any medicine, it can cause side effects. Most people have mild, local effects at the application site, but more serious effects are possible. Here’s a quick overview.
Common (likely) side effects
- Redness, itching, burning, or stinging at the treated skin
- Skin irritation or dry skin at the application area
- Acne
- Headache
- Upper respiratory symptoms like throat irritation or runny nose
Less common or possible side effects
- Worsening skin irritation or an allergic reaction at the application site (rash, swelling)
- Flu-like symptoms (fever, fatigue)
Serious side effects (seek medical attention right away)
- Signs of infection: fever, chills, persistent sore throat, increasing redness, warmth, swelling, or pus at the treated site
- Severe allergic reaction: rash, itching/swelling of face or lips, trouble breathing
- Severe skin reactions (uncommon): widespread skin redness, blistering, peeling
- Signs of liver or bile duct problems: yellowing of skin/eyes, dark urine, persistent stomach pain
- Severe dizziness, fainting, or unusual bleeding/bruising (rare but possible with JAK inhibitors)
Important safety notes
- Do not use Opzelura on broken or severely irritated skin, near the eyes, mouth, or mucous membranes unless your doctor instructs otherwise.
- Wash hands after applying; avoid excessive use or occluding the treated area unless advised by your clinician.
- There isn’t a lot of drug interaction data for topical Opzelura, but tell your doctor about all medicines you’re using (including other skin products, supplements, or prescription meds).
- Pregnancy and breastfeeding: discuss with your healthcare provider. The safety in pregnancy/breastfeeding hasn’t been established.
- Opzelura is prescribed for specific ages and areas of the body. Use exactly as directed by your clinician.
If you’re already using Opzelura and notice anything unusual, or you’re unsure whether a symptom is related, contact your healthcare provider. If you’d like, I can pull up the current FDA label or give you a patient-friendly summary tailored to your condition (e.g., atopic dermatitis vs. vitiligo).